Global University Venturing

The Engine was among the returning investors for the Rice spinout’s series B round, having previously backed a series A in 2019.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UC Davis spinout Dysonics was acquired by Google last year, it has emerged.

Fraunhofer Society has found minimal impact from lockdowns and the pandemic on the number of spinouts its institutes were able to generate last year.

Lyell Immunopharma co-led a series A round for the gene therapy developer, which partially exploits UW research.

The cancer treatment developer, co-founded by researchers from University of Chicago, has secured funding in a round co-led by Arix Bioscience and RTW Investments.

The developer of epigenetic medicine, based on Whitehead Institute research, pulled in funding through a round led by founding investor Flagship Pioneering.

The cancer therapy developer, which is commercialising research from University of Texas, has raised series B1 and B2 financing.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The online learning platform developer spun out of Stanford University priced its shares at the top of their range.

CWRU and UTMC-linked Rodeo Therapeutics is set to be acquired by Amgen for $55m in upfront and up to $666m in milestone payments.